The use of Zn-desferrioxamine for radioprotection in mice, tissue culture, and isolated DNA

Cancer Research

Volumn 59, Issue 2, 1999, Pages 405-409

  Samuni, Yuval ^c   Coffin, Deborah ^a   DeLuca, Anne Marie ^a   DeGraff, William G ^a   Venson, David J ^a   Ambudkar, Indu ^b   Chevion, Mordechai ^c   Mitchell, James B ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; DNA; IRON; OXYGEN; RADIOPROTECTIVE AGENT; RADIOSENSITIZING AGENT; ZINC COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CHINESE HAMSTER; CONTROLLED STUDY; GAMMA RADIATION; HEMODYNAMIC MONITORING; IRON CHELATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RADIOSENSITIVITY; WHOLE BODY RADIATION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CRICETINAE; CRICETULUS; DEFEROXAMINE; DNA; FEMALE; HEMODYNAMIC PROCESSES; MICE; MICE, INBRED C3H; RADIATION-PROTECTIVE AGENTS; WHOLE-BODY IRRADIATION; ZINC;

EID: 0033556094     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Halliwell, B., and Gutteridge, J. M. C. Free Radicals in Biology and Medicine, pp. 160-165. New York: Clarendon Press, 1988.
2. Chevion, M. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radical Biol. Med., 5: 27-37, 1988.
3. Nelson, J. M., and Stevens, R. G. Ferritin-iron increases killing of Chinese hamster ovary cells by X-irradiation. Cell Prolif. 25: 579-585, 1992.
4. Cramp, W. A. Radiosensitization by copper ions, and consequent reversal of the oxygen effect. Nature (Lond.), 206: 636-637, 1965.
5. Anbar, M., and Levitzki, A. Copper-induced radiolytic deactivation of α-amylase and catalase. Radiat. Res., 27: 32-40, 1966.
6. Kirschner, I., Citri, N., Levitzki, A., and Anbar, M. The effect of copper on the radiosensitivity of bacteria. Int. J. Radial. Biol. Relat. Stud. Phys. Chem. Med., 17: 81-85, 1970.
7. Savoye, C., Sabattier, R., Charlier, M., and Spotheim, M. M. Sequence-modulated radiosensitization of DNA by copper ions. Int. J. Radiat. Biol., 70: 189-198, 1996.
8. Roy, M. B., Mandai, P. C., and Bhattacharyya, S. N. Radiosensitization of thymine by copper(II) and nickel(II) complexes of metronidazole. Int. J. Radiat. Biol., 69: 471-480, 1996.
9. Russanov, E., Balevska, P., and Leutshev, S. X-irradialion effects on lipid peroxidation and superoxide dismutase and catalase activities in copper deficient and copper loaded rat liver. Acta Physiol. Pharmacol. Bulg., 5: 73-78, 1979.
10. Soderberg, L. S., Barnett, J. B., Baker, M. L., Salari, H., and Sorenson, R. J. Copper(II)(3,5-diisopropylsalicylate)2 accelerates recovery of B and T cell reactivity following irradiation. Scand. J. Immunol., 26: 495-502, 1987.
11. Soderberg, L. S., Barnett, J. B., Baker, M. L., Salari, H., and Sorenson, J. R. Postirradiation treatment with copper(II)2(3,5-diisopropylsalicylate)4 enhances radiation recovery and hemopoietic regeneration. Exp. Hematol., 18: 801-805, 1990.
12. Sorenson, J. J., Soderberg, L. S., Baker, M. L., Barnett, J. B., Chang, L. W., Salari, H., and Willingham, W. M. Radiation recovery agents: Cu(II), Mn(II), Zn(II), or Fe(III) 3,5-diisopropylsalicylate complexes facilitate recovery from ionizing radiation induced radical mediated tissue damage. Adv. Exp. Med. Biol., 264: 69-77, 1990.
13. Sorenson, J. R. Essential metalloelement metabolism and radiation protection and recovery. Radiat. Res., 132: 19-29, 1992.
14. Sorenson, J. R., Soderberg, L. S., and Chang, L. W. Radiation protection and radiation recovery with essential metalloelement chelates. Proc. Soc. Exp. Biol. Med., 210: 191-204, 1995.
15. Ward, W. F., Molteni, A., Fitzsimons, E. J., and Hinz, J. Serum copper concentration as an index of lung injury in rats exposed to hemithorax irradiation. Radiat. Res., 114: 613-620, 1988.
16. Berenshtein, E. Mayer, B., Goldberg, C., Kitrossky, N., and Chevion, M. Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury. J. Mol. Cell Cardiol., 29: 3025-3034, 1997.
17. Modell, B., Letsky, E. A., Flynn, D. M., Peto, R., and Weattherall, D. J. Survival and desferrioxamine in thalassaemia major. Br. Med. J., 284: 1081-1084, 1982.
18. MacLaren, G. D., Muir, W. A., and Kellermeyer, R. W. Iron overload disorders: natural history, pathogenesis, diagnosis and therapy. CRC Crit. Rev. Clin. Lab. Sci., 19: 205-265, 1983.
19. Porter, J. B., Huehns, H. R., and Hider, R. C. Iron Chelating Therapy. In: Hershko, C. (ed.), Bailliere's Clinical Haematology. 2, pp, 251-292. London: Bailliere Tindall, 1989.
20. Gutteridge, J. M., Richmond, R., and Halliwell, B. Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem. J., 184: 469-472, 1979.
21. Halliwell, B. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radical Biol. Med., 7: 645-651, 1989.
22. Zhu, B-Z., Har-El, R., Kitrossky, N., and Chevion, M. New modes of action of desferrioxamine: scavenging of semiquinone radical and stimulation of hydrolysis of tetrachlorohydroquinone. Free Radical Biol. Med., 24: 360-369, 1998.
23. Florence, A. T., and Attwood, D. Physiochemical Principles of Pharmacy, pp. 335-348. London: Macmillan, 1981.
24. Porter, J. B., Gyparaki, M., Burke, L. C., Huehns, K. R., Sarpong, P., Saez, V., and Hider, R. C. Iron mobilisation from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron binding constant. Blood. 72: 1497-1503, 1988.
25. Rice-Evans, C., Baysal, H., Singh, S., Jones, S. A., and Jones, J. G. The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes. FEBS Lett., 256: 17-20, 1989.
26. Lloyd, J. B., Cable, H., and Rice-Evans, C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem. Pharmacol., 41: 1361-1363, 1991.
27. Knight, J. A., Searles, D. A., and Blaylock, R. C. The effect of metal ehelators on lipid peroxidation in irradiated erythrocytes. Ann. Clin. Lab. Sci., 22: 417-422, 1992.
28. Knight, J. A., Blaylock, R. C., and Searles, D. A. Lipid peroxidation in platelet concentrates: effects of irradiation and metal chelators. Ann. Clin. Lab. Sci., 23: 333-339, 1993.
29. Singh, A., Singh, H., and Henderson, J. S. Radioprotection by ascorbic acid, desferal, and mercaptoethylamine. Methods Enzymol. 186: 686-696, 1990.
30. Juckett, M. B., Shadley, J. D., Zheng, Y., and Klein, J. P. Desferrioxamine enhances the effects of gamma radiation on clonogenic survival and the formation of chromosomal aberrations in endothelial cells. Radial. Res., 149: 330-337, 1998.
31. Ophir, A., Berenshtein, H., Kitrossky, N., and Averbukh, B. Protection of the transiently ischemic cat retina by zine-desferroxamine. Invest. Ophthalmol. Vis. Sci., 35: 1212-1222, 1994.
32. Siganos, C. S., Frucht, P. J., Muallem, M. S., Berenshtein, E., Naoumidi, I., Ever, H. P., Pallikaris, I. G., Siganos, D. S., and Chevion, M. Topical use of zinc desferrioxamine for corneal alkali injury in a rabbit model. Cornea. 17: 191-195, 1998.
33. Nagler, R., Marmary, Y., Golan, E., and Chevion, M. Novel protection strategy against X-ray-induced damage to salivary glands. Radiat. Res., 149: 271-276, 1998.
34. Chevion, M. Protection against free radical-induced and transition metal-mediated damage: the use of "pull" and "push" mechanisms. Free Radical Res. Commun., 2: 691-696, 1991.
35. Chevion, M., Chuang, L., and Golenser, J. Effects of zinc-desferrioxamine on Plasmodium falciparum in culture. Antimicrob. Agents Chemother., 39: 1902-1905, 1995.
36. Cameron J. R., Suntharalingam, N., and Kenney G. N. Thermoluminescent Dosimetry, p. 232. Madison: University of Wisconsin Press, 1968.
37. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning, pp. 121-152. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
38. Krishna, M. C., DeGraff, W., Tamura, S., Gonzalez, F. J., Samuni, A., Russo, A., and Mitchell, J. B. Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in Chinese hamster V79 cells. Cancer Res., 51: 6622-6628, 1991.
39. Samuni, A., Chevion, M., and Czapski, G. Unusual copper-induced sensitization of the biological damage due to superoxide radicals. J. Biol. Chem., 256: 12632-12635, 1981.
40. Har-El, R., and Chevion, M. Zinc(II) protects against metal-mediated free radical induced damage: studies on single and double-strand DNA breakage. Free Radical Res. Commun., 2: 509-515, 1991.
41. Floersheim, G. L., Chiodetti, N., and Bieri, A. Differential radioprotection of bone marrow and tumour cells by zinc aspartate. Br. J. Radiol., 61: 501-508, 1988.
42. Floersheim, G. L., and Floersheim, P. Protection against ionising radiation and synergism with thiols by zinc aspartate. Br. J. Radiol., 59: 597-602, 1986.
43. Floersheim, G. L., and Bieri, A. Further studies on selective radioprotection by organic zinc salts and synergism of zinc aspartale with WR 2721. Br. J. Radiol., 63: 468-475, 1990.
44. Mitchell, J. B., DeGraff, W., Kaufman, D., Krishna, M. C., Samuni, A., Finkelstein, E., Ahn, M. S., Hahn, S. M., Gamson, J., and Russo, A. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempot. Arch. Biochem. Biophys., 289: 62-70, 1991.
45. Krishna, M. C., Halevy, R. F., Zhang, R., Gutierrez, P. L., and Samuni, A. Modulation of streptonigrin cytotoxicity by nitroxide SOD mimics. Free Radical Biol. Med., 17: 379-388, 1994.
46. Kontoghiorghes, G. J., Piga, A., and Hoffbrand, A. V. Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines. Hematol. Oncol., 4: 195-204, 1986.
47. Matsubara, J., Shida, T., Ishioka, K., Egawa, S., Inada, T., and Machida, K. Protective effect of zinc against lethality in irradiated mice. Environ. Res., 41: 558-567, 1986.
48. Peters, G., Keberle, H., Schmid, K., an Brunner, H. Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem. Pharmacol., 15: 93-109, 1966.